Cerebral ischemia: new risk factors
1S Neurología, Hospital 12 de Octubre, Madrid, Spain.
Insights
New research identifies key stroke risk factors beyond traditional ones. These include inflammation (C-reactive protein), infection, homocysteine, and sleep-disordered breathing, offering new avenues for prevention and treatment.
Area of Science:
- Neurology
- Cardiovascular Medicine
- Public Health
Background:
- Established modifiable risk factors (hypertension, smoking, diabetes, hyperlipidemia, atrial fibrillation) explain only half of cardiovascular disease risk.
- Identifying novel risk factors is crucial for comprehensive stroke prevention strategies.
- Cerebral atherosclerosis necessitates understanding beyond conventional risk factors.
Purpose of the Study:
- To review and highlight emerging risk factors for stroke, particularly in the context of cerebral atherosclerosis.
- To discuss the clinical significance and potential management of these new risk factors.
- To emphasize the importance of considering these factors in stroke patient evaluation and care.
Main Methods:
- Literature review and synthesis of current research on novel stroke risk factors.
- Focus on inflammatory markers, infections, homocysteine levels, and sleep-disordered breathing.
- Analysis of evidence regarding C-reactive protein, Chlamydia pneumoniae, homocysteine, and sleep apnea.
Main Results:
- Elevated C-reactive protein is a significant risk factor for heart disease and thromboembolic stroke.
- The role of Chlamydia pneumoniae in stroke remains debated.
- Influenza vaccination is a proven preventive measure against stroke.
- Homocysteine's clinical benefit from vitamin therapy requires further trial data.
- Sleep-disordered breathing is a potential risk factor with effective therapeutic options.
Conclusions:
- Inflammatory markers, infection, homocysteine, and sleep-disordered breathing are key emerging stroke risk factors.
- Neurologists should actively screen stroke patients for sleep disorders and consider early intervention with breathing therapy.
- Further research is needed to clarify the role of certain factors like Chlamydia pneumoniae and the benefits of homocysteine reduction therapies.
Abstract:
Stroke is a disease with well-defined modifiable risk factors such as arterial hypertension, smoking, diabetes, hyperlipidemia and atrial fibrillation. The need of new risk factors is based on the fact that only half the cardiovascular disease risk is explained by conventional risk factors. Inflammatory markers, infection, homocysteine and sleep-disordered breathing rank as the four most important new risk factors in cerebral atherosclerosis. C-reactive protein is the inflammatory marker that has been most thoroughly studied. Elevated concentrations of C-reactive protein increase the risk of heart disease and thromboembolic stroke in men and women. The role of Chlamydia pneumoniae is still controversial. Influenza vaccination is a simple and effective preventive measure against stroke. Despite the potential relationship between homocysteine and stroke, we should wait to the results of the ongoing trials to know if the reduction of homocysteine levels with vitamin therapy is of clinical benefit. Sleep-disordered breathing is a potential new risk factor with an effective therapy. Neurologists should not forget to look for sleep disorders in their stroke patients and probably manage them with breathing therapy from the acute phase.
Related Concept Videos
01:15Ischemic Stroke l: Introduction
01:15Ischemic Stroke ll: Pathophysiology
01:17Hemorrhagic Stroke l: Introduction
01:17Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
01:26Transient Ischemic Attack l: Introduction
01:22Cerebral Edema ll: Pathophysiology